相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Osteoporosis: Current and Emerging Therapies Targeted to Immunological Checkpoints
Massimo De Martinis et al.
CURRENT MEDICINAL CHEMISTRY (2020)
IL-33/IL-31 Axis in Osteoporosis
Massimo De Martinis et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
IL-33 Inhibits TNF-alpha-Induced Osteoclastogenesis and Bone Resorption
Fumitoshi Ohori et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Interleukin-1β is a potential therapeutic target for periodontitis: a narrative review
Ran Cheng et al.
INTERNATIONAL JOURNAL OF ORAL SCIENCE (2020)
Inhibition of RAGE Axis Signaling: A Pharmacological Challenge
Armando Rojas et al.
CURRENT DRUG TARGETS (2019)
The alarmins IL-1 and IL-33 differentially regulate the functional specialisation of Foxp3+ regulatory T cells during mucosal inflammation
Fernando Alvarez et al.
MUCOSAL IMMUNOLOGY (2019)
RAGE Signaling in Skeletal Biology
Lilian I. Plotkin et al.
CURRENT OSTEOPOROSIS REPORTS (2019)
MyD88 and IL-1R signaling drive antibacterial immunity and osteoclast-driven bone loss during Staphylococcus aureus osteomyelitis
Nicole E. Putnam et al.
PLOS PATHOGENS (2019)
HMGB1 promotes bone fracture healing through activation of ERK signaling pathway in a rat tibial fracture model
Ming-Qi Chen et al.
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2019)
The role of cellular senescence in diabetes mellitus and osteoporosis: molecular pathways and potential interventions
Georgios Giovos et al.
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2019)
Advanced Glycation End Products (AGEs), Receptor for AGEs, Diabetes, and Bone: Review of the Literature
Kamyar Asadipooya et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2019)
The Multitasking Potential of Alarmins and Atypical Chemokines
Aphrodite Kapurniotu et al.
FRONTIERS IN MEDICINE (2019)
Interleukin-33 serum levels in postmenopausal women with osteoporosis
Lia Ginaldi et al.
SCIENTIFIC REPORTS (2019)
IL-1β Induces Pathologically Activated Osteoclasts Bearing Extremely High Levels of Resorbing Activity: A Possible Pathological Subpopulation of Osteoclasts, Accompanied by Suppressed Expression of Kindlin-3 and Talin-1
Takuma Shiratori et al.
JOURNAL OF IMMUNOLOGY (2018)
Targeting RAGE Signaling in Inflammatory Disease
Barry I. Hudson et al.
ANNUAL REVIEW OF MEDICINE, VOL 69 (2018)
Oxidized low-density lipoprotein promotes osteoclast differentiation from CD68 positive mononuclear cells by regulating HMGB1 release
Chunfeng Hou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Blockade of receptors of advanced glycation end products ameliorates diabetic osteogenesis of adipose-derived stem cells through DNA methylation and Wnt signalling pathway
Maorui Zhang et al.
CELL PROLIFERATION (2018)
ST2 regulates bone loss in a site-dependent and estrogen-dependent manner
Soraia Macari et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Irbesartan attenuates advanced glycation end products-mediated damage in diabetes-associated osteoporosis through the AGEs/RAGE pathway
Yan-Zhen Cheng et al.
LIFE SCIENCES (2018)
A ligand-specific blockade of the integrin Mac-1 selectively targets pathologic inflammation while maintaining protective host-defense
Dennis Wolf et al.
NATURE COMMUNICATIONS (2018)
HMGB2 is a novel adipogenic factor that regulates ectopic fat infiltration in skeletal muscles
Deokcheol Lee et al.
SCIENTIFIC REPORTS (2018)
Therapeutic Potentia of DNA-aptamers Raised Against AGE-RAGE Axis in Diabetes-related Complications
Sho-ichi Yamagishi et al.
CURRENT PHARMACEUTICAL DESIGN (2018)
ST2: Current status
Aditi Dattagupta et al.
INDIAN HEART JOURNAL (2018)
HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins
Damien Bertheloot et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2017)
Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective
Salvatore Bongarzone et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Advanced glycation end-products produced systemically and by macrophages: A common contributor to inflammation and degenerative diseases
Kyunghee Byun et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Dectin-1 signaling inhibits osteoclastogenesis via IL-33-induced inhibition of NFATc1
Xiaoqing Zhu et al.
ONCOTARGET (2017)
PREVALENCE AND RISK FACTORS OF OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN WITH TYPE 2 DIABETES MELLITUS
Ivan Raska et al.
CENTRAL EUROPEAN JOURNAL OF PUBLIC HEALTH (2017)
Evaluation of circulating sRAGE in osteoporosis according to BMI, adipokines and fracture risk: a pilot observational study
Emanuela Galliera et al.
IMMUNITY & AGEING (2017)
Extracellular S100A4 negatively regulates osteoblast function by activating the NF-κB pathway
Haemin Kim et al.
BMB REPORTS (2017)
The multiple faces of RAGE - opportunities for therapeutic intervention in aging and chronic disease
Ravichandran Ramasamy et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2016)
Advanced glycation end products biphasically modulate bone resorption in osteoclast-like cells
Ziqing Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2016)
IL-33 circulating serum levels are increased in patients with non-segmental generalized vitiligo
Mario Vaccaro et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2016)
Potential Therapeutic Aspects of Alarmin Cytokine Interleukin 33 or Its Inhibitors in Various Diseases
Muhammad Imran Arshad et al.
CLINICAL THERAPEUTICS (2016)
Osteoimmunology and Beyond
Lia Ginaldi et al.
CURRENT MEDICINAL CHEMISTRY (2016)
Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer's disease patients
Francesco Panza et al.
EXPERT OPINION ON EMERGING DRUGS (2016)
Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; Overview of clinical evidence and potential contributions to disease
Niki L. Reynaert et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2016)
Regulation of Receptor for Advanced Glycation End Products (RAGE) Ectodomain Shedding and Its Role in Cell Function
Alex Braley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
HMGB1 promotes the secretion of multiple cytokines and potentiates the osteogenic differentiation of mesenchymal stem cells through the Ras/MAPK signaling pathway
Lin Feng et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2016)
IL-1 drives breast cancer growth and bone metastasis in vivo
Ingunn Holen et al.
ONCOTARGET (2016)
Advanced Glycation End Products, Diabetes, and Bone Strength
Masahiro Yamamoto et al.
CURRENT OSTEOPOROSIS REPORTS (2016)
ARTD1 regulates osteoclastogenesis and bone homeostasis by dampening NF-κB-dependent transcription of IL-1β
Agnieszka Robaszkiewicz et al.
SCIENTIFIC REPORTS (2016)
IL-33 inhibits RANKL-induced osteoclast formation through the regulation of Blimp-1 and IRF-8 expression
Hiroyasu Kiyomiya et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Increased levels of interleukin 31 (IL-31) in osteoporosis
Lia Ginaldi et al.
BMC IMMUNOLOGY (2015)
Glucocorticoids in Patients with Rheumatic Diseases: Friends or Enemies of Bone?
Fedra Ciccarelli et al.
CURRENT MEDICINAL CHEMISTRY (2015)
IL-33/ST2 axis controls Th2/IL-31 and Th17 immune response in allergic airway diseases
Lavinia Vocca et al.
IMMUNOBIOLOGY (2015)
The inflammasome and IL-1β: implications for the treatment of inflammatory diseases
Takashi Satoh et al.
IMMUNOTHERAPY (2015)
Advanced Glycation End Products Affect Osteoblast Proliferation and Function by Modulating Autophagy Via the Receptor of Advanced Glycation End Products/Raf Protein/Mitogen-activated Protein Kinase/Extracellular Signalregulated Kinase Kinase/Extracellular Signal-regulated Kinase (RAGE/Raf/MEK/ERK) Pathway
Hong-Zheng Meng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
A direct role of collagen glycation in bone fracture
Atharva A. Poundarik et al.
JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS (2015)
OSTEOIMMUNOLOGY IN 2014 Two-faced immunology-from osteogenesis to bone resorption
Hiroshi Takayanagi
NATURE REVIEWS RHEUMATOLOGY (2015)
Interleukin 33: a switch-hitting cytokine
Daniel O. Villarreal et al.
CURRENT OPINION IN IMMUNOLOGY (2014)
Collagen Modifications in Postmenopausal Osteoporosis: Advanced Glycation Endproducts May Affect Bone Volume, Structure and Quality
Thomas L. Willett et al.
CURRENT OSTEOPOROSIS REPORTS (2014)
RAGE in tissue homeostasis, repair and regeneration
Guglielmo Sorci et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
Functions of S100 Proteins
R. Donato et al.
CURRENT MOLECULAR MEDICINE (2013)
S100A16 inhibits osteogenesis but stimulates adipogenesis
Dong Li et al.
MOLECULAR BIOLOGY REPORTS (2013)
Receptor for Advanced Glycation End Products and Its Involvement in Inflammatory Diseases
Yaw Kuang Chuah et al.
INTERNATIONAL JOURNAL OF INFLAMMATION (2013)
Transgenic over-expression of interleukin-33 in osteoblasts results in decreased osteoclastogenesis
Johannes Keller et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
S100 proteins in cartilage: Role in arthritis
Raghunatha R. Yammani
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)
A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease
Rashid Deane et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
被撤回的出版物: Redox Modification of Cysteine Residues Regulates the Cytokine Activity of High Mobility Group Box-1 (HMGB1) (Publication with Expression of Concern. See vol. 26, 2020) (Retracted article. See vol. 26, 2020)
Huan Yang et al.
MOLECULAR MEDICINE (2012)
S100A8 Enhances Osteoclastic Bone Resorption In Vitro Through Activation of Toll-like Receptor 4 Implications for Bone Destruction in Murine Antigen-Induced Arthritis
Lilyanne C. Grevers et al.
ARTHRITIS AND RHEUMATISM (2011)
Interleukin-33, a Target of Parathyroid Hormone and Oncostatin M, Increases Osteoblastic Matrix Mineral Deposition and Inhibits Osteoclast Formation in Vitro
Hasnawati Saleh et al.
ENDOCRINOLOGY (2011)
Interleukin-33 Is Expressed in Differentiated Osteoblasts and Blocks Osteoclast Formation From Bone Marrow Precursor Cells
Jochen Schulze et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
IL-33 Shifts the Balance from Osteoclast to Alternatively Activated Macrophage Differentiation and Protects from TNF-α-Mediated Bone Loss
Mario M. Zaiss et al.
JOURNAL OF IMMUNOLOGY (2011)
Role of IL-33 in inflammation and disease
Ashley M. Miller
JOURNAL OF INFLAMMATION-LONDON (2011)
Interleukin-33 stimulates formation of functional osteoclasts from human CD14+ monocytes
Se Hwan Mun et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
IL-33 family members and asthma - bridging innate and adaptive immune responses
Clare M. Lloyd
CURRENT OPINION IN IMMUNOLOGY (2010)
Low Serum Level of the Endogenous Secretory Receptor for Advanced Glycation End Products (esRAGE) Is a Risk Factor for Prevalent Vertebral Fractures Independent of Bone Mineral Density in Patients With Type 2 Diabetes
Masahiro Yamamoto et al.
DIABETES CARE (2009)
Direct Inhibitory and Indirect Stimulatory Effects of RAGE Ligand S100 on sRANKL-Induced Osteoclastogenesis
Tomohiko Yoshida et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
The Mechanism of Osteoclast Differentiation Induced by IL-1
Jung Ha Kim et al.
JOURNAL OF IMMUNOLOGY (2009)
Therapeutic potential of HMGB1-targeting agents in sepsis
Haichao Wang et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2008)
HMGB1 regulates RANKL-induced osteoclastogenesis in a manner dependent on RAGE
Zheng Zhou et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
High-mobility group box proteins modulate tumor necrosis factor-α expression in osteoclastogenesis via a novel deoxyribonucleic acid sequence
Kosj Yamoah et al.
MOLECULAR ENDOCRINOLOGY (2008)
HMGB1 is a bone-active cytokine
Jieping Yang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
Structural and functional insights into RAGE activation by multimeric S100B
Thorsten Ostendorp et al.
EMBO JOURNAL (2007)
Stage-specific secretion of HMGB1 in cartilage regulates endochondral ossification
Noboru Taniguchi et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
DAMPs, PAMPs and alarmins: all we need to know about danger
Marco E. Bianchi
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Apoptosis remodeling in immunosenescence: Implications for strategies to delay ageing
Massimo De Martinis et al.
CURRENT MEDICINAL CHEMISTRY (2007)
The use of anakinra, an interleukin-1 receptor antagonist, in the treatment of rheumatoid arthritis
SB Cohen
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2004)
Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine function
S Müller et al.
JOURNAL OF INTERNAL MEDICINE (2004)
Proinflammatory S100 proteins in arthritis and autoimmune disease
D Foell et al.
ARTHRITIS AND RHEUMATISM (2004)
Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE)
LE Hanford et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The role of interleukin-1 in bone resorption in rheumatoid arthritis
V. Strand et al.
RHEUMATOLOGY (2004)
Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis - Effects on synovial inflammation, bone erosion, and cartilage destruction
J Zwerina et al.
ARTHRITIS AND RHEUMATISM (2004)
Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis:: comparison with IL1β and tumour necrosis factor α
SM Dai et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature)
I Marenholz et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion
T Bonaldi et al.
EMBO JOURNAL (2003)
HMGB proteins and gene expression
A Agresti et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2003)
S100A4: A novel negative regulator of mineralization and osteoblast differentiation
WR Duarte et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
The DNA chaperone HMGB1 facilitates ACF/CHRAC-dependent nucleosome sliding
T Bonaldi et al.
EMBO JOURNAL (2002)
Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage
SB Abramson et al.
RHEUMATOLOGY (2002)
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
P Scaffidi et al.
NATURE (2002)
The biology of the receptor for advanced glycation end products and its ligands
AM Schmidt et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2000)
Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice
E Lalla et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
分享论文
